[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100366414":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":26,"responsibleParty":46,"collaborators":48,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Myocardial infarction",null,"As it is an observational study, no intervention is planned. However, nested clinical interventional trials are planned for which a specific registration will be done",[13],{"name":14,"affiliation":5,"role":15},"Philippe Gabriel STEG","PRINCIPAL_INVESTIGATOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Tabassome SIMON","CONTACT","01 40 01 13 93","tabassome.simon@aphp.fr",{"name":14,"role":19,"phone":23,"phoneExt":24,"email":25},"01 40 25 80 80","+33","gabriel.steg@aphp.fr",[27],{"facility":28,"status":29,"city":30,"state":10,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Hôpital Bichat, AP-HP","RECRUITING","Paris","75018","France","FR",{"type":35,"coordinates":36},"Point",[37,38],2.3488,48.85341,{"lat":38,"lon":37},[41,44],{"name":42,"role":19,"phone":43,"phoneExt":10,"email":25},"Philippe gabriel STEG, PU-PH","00 33 01 40 25 89 69",{"name":45,"role":15,"phone":10,"phoneExt":10,"email":10},"Nicolas DANCHIN",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[49],{"name":50,"class":51},"Novartis","INDUSTRY","100366414","french-cohort-of-myocardial-infarction-evaluation-100366414",false,"NCT04050956","French Cohort of Myocardial Infarction Evaluation","FRENCHIE","Inclusion Criteria:\n\n* Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements :\n* Symptoms compatible with myocardial ischemia\n* Appearance of pathological Q waves\n* ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)\n* Written consent.\n* Covered by French medical insurance (\"Sécurité Sociale\")\n\nExclusion Criteria:\n\n* Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure\n* AMI diagnosis invalidated in favor of another diagnosis","ALL","18 Years",{"count":62,"type":63},30000,"ESTIMATED","OBSERVATIONAL","Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless, the evolution of care practices and their impact on the mid- and long-term prognosis of patients admitted to the intensive care unit for acute myocardial infarction remain relatively little studied exhaustively.\n\nThe aim of this study is to assess the profile of AMI patients, their management and follow-up in order to evaluate the relationship between these factors and outcomes.",[67],"Acute Myocardial Infarction",[67,69,70,71,72],"Registry","Outcomes","Medico-economic evaluation","Comorbidities","2025-06-20",{"date":75,"type":76},"2025-06-25","ACTUAL",{"date":78,"type":76},"2019-03-11",{"date":80,"type":63},"2049-03-22",{"name":5,"class":6},1]